1. Home
  2. ADCT vs CAAS Comparison

ADCT vs CAAS Comparison

Compare ADCT & CAAS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ADCT
  • CAAS
  • Stock Information
  • Founded
  • ADCT 2011
  • CAAS N/A
  • Country
  • ADCT Switzerland
  • CAAS China
  • Employees
  • ADCT N/A
  • CAAS N/A
  • Industry
  • ADCT Biotechnology: Pharmaceutical Preparations
  • CAAS Auto Parts:O.E.M.
  • Sector
  • ADCT Health Care
  • CAAS Consumer Discretionary
  • Exchange
  • ADCT Nasdaq
  • CAAS Nasdaq
  • Market Cap
  • ADCT 143.1M
  • CAAS 122.3M
  • IPO Year
  • ADCT 2020
  • CAAS N/A
  • Fundamental
  • Price
  • ADCT $1.63
  • CAAS $4.58
  • Analyst Decision
  • ADCT Strong Buy
  • CAAS
  • Analyst Count
  • ADCT 5
  • CAAS 0
  • Target Price
  • ADCT $8.00
  • CAAS N/A
  • AVG Volume (30 Days)
  • ADCT 493.2K
  • CAAS 34.6K
  • Earning Date
  • ADCT 03-12-2025
  • CAAS 03-27-2025
  • Dividend Yield
  • ADCT N/A
  • CAAS N/A
  • EPS Growth
  • ADCT N/A
  • CAAS 2.02
  • EPS
  • ADCT N/A
  • CAAS 1.05
  • Revenue
  • ADCT $70,717,000.00
  • CAAS $621,377,000.00
  • Revenue This Year
  • ADCT $6.81
  • CAAS $4.97
  • Revenue Next Year
  • ADCT $11.23
  • CAAS N/A
  • P/E Ratio
  • ADCT N/A
  • CAAS $4.36
  • Revenue Growth
  • ADCT N/A
  • CAAS 13.81
  • 52 Week Low
  • ADCT $1.39
  • CAAS $3.17
  • 52 Week High
  • ADCT $5.38
  • CAAS $4.97
  • Technical
  • Relative Strength Index (RSI)
  • ADCT 46.49
  • CAAS 72.01
  • Support Level
  • ADCT $1.55
  • CAAS $4.38
  • Resistance Level
  • ADCT $1.73
  • CAAS $4.54
  • Average True Range (ATR)
  • ADCT 0.12
  • CAAS 0.17
  • MACD
  • ADCT 0.03
  • CAAS 0.05
  • Stochastic Oscillator
  • ADCT 63.16
  • CAAS 98.71

About ADCT ADC Therapeutics SA

ADC Therapeutics SA is a commercial-stage oncology-focused biotechnology company. It is involved in the development of antibody-drug conjugates for patients suffering from hematological malignancies and solid tumors. The company's product candidate includes ZYNLONTA, camidanlumab tesirine, ADCT-602, ADCT-601, ADCT-901, ADCT-701 and ADCT-212.

About CAAS China Automotive Systems Inc.

China Automotive Systems Inc is a holding company. The firm through its subsidiary is a supplier of power steering systems and components to China's automotive industry. Its product offering encompasses a full range of auto parts incorporated into steering systems for both passenger automobiles and commercial vehicles. The company offers four separate series, more than 310 models of power steering including rack and pinion power steering, integral power steering, electronic power steering and manual steering, steering columns, steering oil pumps, and steering hoses. Geographically, it derives a majority of its revenue from China.

Share on Social Networks: